How to Trade Pre-IPO or Tokenized Private Company Exposure on ApeX

There’s no public market price for a company that hasn’t gone public, so a pre-IPO perpetual contract settles against a market-implied estimate of the company’s per-share value instead, a fundamentally more speculative pricing basis than any of the other perpetual products covered in this series.

This guide is part of TradeOnDEX’s ApeX Protocol how-to series within Perpetual Futures.

Disclosure: TradeOnDEX may earn a commission from links to ApeX on this page, at no extra cost to you. Full details at the end of this article.

What you’re actually trading

Pre-IPO perpetual futures let traders take leveraged positions on synthetic prices tied to a private company’s expected valuation, companies like SpaceX, OpenAI, and Anthropic have all had tracked pre-IPO perpetual markets across various platforms. These contracts offer price exposure with no equity rights whatsoever, settling against a market-implied estimate of the firm’s per-share value rather than an actual traded market price, since the company simply isn’t publicly listed.

This means for you, concretely: you’re speculating on a valuation estimate that market participants collectively arrive at, not trading against a verifiable, exchange-quoted share price the way you would with a public stock, the underlying reference itself is inherently less anchored than what backs the stock perpetuals covered elsewhere in this series.

The real legal risk this space carries

This is the single most important risk to understand before trading pre-IPO exposure of any kind: private companies like OpenAI and Anthropic have actively cracked down on secondary sales of their shares, and are legally positioned to void such transactions. Shares (or exposure instruments) purchased through secondary marketplaces or special-purpose vehicles (SPVs) tied to a private company’s stock could become worthless before that company’s actual IPO, entirely independent of how the company itself performs.

The cost structure worth understanding

Exposure to private companies through SPVs or similar structures can carry meaningfully higher costs than owning public shares outright, reported access fees have ranged from under 5% to as much as 18%, and investors can end up paying compounding fees through multiple stacked vehicles layered on top of each other. A perpetual contract structure is different from an SPV specifically, but the underlying lesson generalizes: exposure to a private, illiquid company is often structurally more expensive and more layered than it first appears.

How to approach this category, step by step

1. Understand explicitly that you have no equity rights, no shareholder claim, and no direct legal relationship with the underlying private company through this instrument.
2. Check which specific companies currently have active, liquid pre-IPO perpetual markets before assuming broad private-company coverage.
3. Size any position conservatively, given the added layer of valuation-estimate risk on top of standard leverage risk.
4. Stay aware of the specific company’s own stance on secondary exposure to its shares, since crackdowns and legal actions in this space are real and ongoing, not hypothetical.

Risk: what’s genuinely different (and riskier) about this category

The settlement reference is a valuation estimate, not a verifiable market price. Unlike a stock perpetual referencing an actual public share price via Chainlink, a pre-IPO perpetual settles against what the market collectively believes the company is worth, a materially less anchored, more speculative pricing basis than anything else in this series’ RWA coverage.

Underlying legal risk exists independent of platform or contract structure. A private company actively voiding secondary transactions in its shares is a real, documented pattern (specifically cited for OpenAI and Anthropic), while a perpetual contract isn’t the same legal instrument as directly-purchased secondary shares, this underlying corporate hostility toward unauthorized secondary exposure is relevant context for the entire category of private-company exposure products, not just one specific structure.

Volume and interest in this category can be extremely volatile around real corporate events. Reported trading volume for SpaceX pre-IPO perpetuals surged dramatically ahead of an actual public listing event, illustrating how sharply interest (and likely liquidity and pricing volatility) in this category can shift around real-world corporate milestones.

This is a genuinely new and rapidly evolving product category with limited track record. Pre-IPO perpetual markets across the industry, including on ApeX, are a recent development. Treat this as one of the least-established, least-precedented products covered anywhere in this content series, deserving proportionally more caution.

Combining leverage with an already more speculative valuation-estimate pricing basis compounds risk on two fronts simultaneously. As with leveraged prediction markets covered elsewhere in this series, adding leverage on top of an already less-anchored pricing reference means both the underlying valuation uncertainty and the leverage-driven liquidation risk compound together, not separately.

Pre-IPO perpetuals vs. stock perpetuals vs. actual equity

See it for yourself

Before trading any pre-IPO exposure product, confirm you understand exactly what price reference it settles against and how recently that specific market was established, treating this category with more caution than the platform’s public stock perpetuals given its shorter track record and less-anchored pricing basis.

Frequently asked questions

Do I own actual private company shares when trading a pre-IPO perpetual on ApeX?

No, these are synthetic derivatives settling against a market-implied valuation estimate, with no equity rights or ownership claim in the underlying private company.

Is there a real legal risk to private-company secondary exposure generally?

Yes, companies like OpenAI and Anthropic have documented histories of actively cracking down on and voiding unauthorized secondary transactions in their shares, relevant broader context for this entire product category.

How is a pre-IPO perpetual’s price determined if the company isn’t publicly traded?

Against a market-implied estimate of the company’s per-share value, a materially less anchored reference than an actual public market price.

Is this a well-established, low-risk product category?

No, pre-IPO perpetual markets are a genuinely new and rapidly evolving category industry-wide, with limited operating history compared to more established perpetual products.

Affiliate disclosure

TradeOnDEX may earn a commission if you sign up or trade through a link on this page, at no extra cost to you. ApeX’s own affiliate/referral terms are still being confirmed for this site, so links here are direct and untracked for now. This article is educational and is not financial advice; pre-IPO exposure products carry risks distinct from and generally greater than standard crypto or public-equity perpetuals. See our disclaimer for the full risk warning.